Logesh Babu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Logesh Babu has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Mulavagili Vijayasimha
University Institute of Allied Health Science, Chandigarh University
3 shared publications - Mulavagili Srikanth
Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences
2 shared publications - Sai Charan Labishetty
Department of Optometry, University Institute of Allied Health Sciences, Chandigarh University
2 shared publications - Tara Rani
Department of Optometry, University Institute of Allied Health Sciences, Chandigarh University, Mohali, India
2 shared publications - Devadass Jayarajan
Dept of MLT, Faculty of Paramedical Sciences, Assam Downtown University, Gauwhathi, India
1 shared publication M Mbbs Srikanth
Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Medical Rd, Rohtak, Haryana 124001, India
1 shared publication
Latest Publications
- 16 June 2026
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 52 (9) , 954-955
Comment on: Evaluating large language models vs residents in cataract and refractive surgery: comparative analysis using the American Academy of Ophthalmology Self-Assessment Program
Purpose: To critically evaluate new evidence regarding big language models (LLMs) in cataract and refractive surgery and suggest a clinically responsible validation system. Methods: Conceptual synthesis of the recent literature of high impact and comment on a recent JCRS study on the performance of LLM compared to ophthalmology residents. Findings: Despite the high benchmark performance of LLMs, there are still severe deficits in clinical reliability, reproducibility, citation traceability, and safety in anterior-segment procedures. It proposes a three-layer validation pipeline, which includes domain-specific benchmarking, multi-dimensional performance reporting, and use-case-based deployment thresholds. Conclusions: It is necessary to shift the accuracy of examination to responsible clinical integration. An equity-sensitive validation framework applicable globally can make the application of AI in cataract and refractive surgery safe, transparent, and effective.
- 16 June 2026
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 52 (9) , 954-955
Comment on: Evaluating large language models vs residents in cataract and refractive surgery: comparative analysis using the American Academy of Ophthalmology Self-Assessment Program
Purpose: To critically evaluate new evidence regarding big language models (LLMs) in cataract and refractive surgery and suggest a clinically responsible validation system. Methods: Conceptual synthesis of the recent literature of high impact and comment on a recent JCRS study on the performance of LLM compared to ophthalmology residents. Findings: Despite the high benchmark performance of LLMs, there are still severe deficits in clinical reliability, reproducibility, citation traceability, and safety in anterior-segment procedures. It proposes a three-layer validation pipeline, which includes domain-specific benchmarking, multi-dimensional performance reporting, and use-case-based deployment thresholds. Conclusions: It is necessary to shift the accuracy of examination to responsible clinical integration. An equity-sensitive validation framework applicable globally can make the application of AI in cataract and refractive surgery safe, transparent, and effective.
- Open Access
- 30 May 2026
- Published by Atlantis Press SARL
- p. 41-62
Nano-Patterned Wetting Layers on Silicone Hydrogels: Toward Continuous-Wear Contact Lenses with Enhanced Oxygen Flux
- 30 May 2026
- Published by Atlantis Press SARL
- p. 41-62
Open AccessNano-Patterned Wetting Layers on Silicone Hydrogels: Toward Continuous-Wear Contact Lenses with Enhanced Oxygen Flux
- 12 April 2026
- Published by Taylor & Francis in Clinical and Experimental Optometry
- Vol. 109 (7) , 1-2
Re: Impact of digital versus faxed e-referrals on triage decisions in a medical retina clinic
To the editor,We read with great interest the recent article by McGuinness and colleagues on the impact of digital versus faxed e-referrals in a medical retina clinic.1 Their study is important bec...
- 12 April 2026
- Published by Taylor & Francis in Clinical and Experimental Optometry
- Vol. 109 (7) , 1-2
Re: Impact of digital versus faxed e-referrals on triage decisions in a medical retina clinic
To the editor,We read with great interest the recent article by McGuinness and colleagues on the impact of digital versus faxed e-referrals in a medical retina clinic.1 Their study is important bec...
- Open Access
- 13 February 2026
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 30 (2) , 177-178
Aminotransferase-to-platelet Ratio Index for Sepsis-associated Liver Dysfunction: Promising Triage Signal but Phenotype Confounding and Implementation Calibration must be Intensive Care Unit Ready
How to cite this article: Vijayasimha M, Srikanth M, Jayarajan D, Babu L, Malinidevi M. Aminotransferase-to-platelet Ratio Index for Sepsis-associated Liver Dysfunction: Promising Triage Signal but Phenotype Confounding and Implementation Calibration must be Intensive Care Unit Ready. Indian J Crit Care Med 2026;30(2):177–178.
- 13 February 2026
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 30 (2) , 177-178
Open AccessAminotransferase-to-platelet Ratio Index for Sepsis-associated Liver Dysfunction: Promising Triage Signal but Phenotype Confounding and Implementation Calibration must be Intensive Care Unit Ready
How to cite this article: Vijayasimha M, Srikanth M, Jayarajan D, Babu L, Malinidevi M. Aminotransferase-to-platelet Ratio Index for Sepsis-associated Liver Dysfunction: Promising Triage Signal but Phenotype Confounding and Implementation Calibration must be Intensive Care Unit Ready. Indian J Crit Care Med 2026;30(2):177–178.
- Open Access
- 29 January 2026
- Published by Chitkara University Publications in Journal of Multidisciplinary Research in Healthcare
- Vol. 12 (1) , 50-55
Digital AI-Based Sensing Technologies in Cancer Care: A PATHS Framework for Early Detection and Personalized Diagnosis
Background: Recent work has mapped a wide range of biotechnological tools for early cancer detection, ranging from microfluidics and liquid biopsy to biosensors, organoids, breath-based diagnostics, and artificial intelligence (AI), with explicit attention to primary and resource-constrained healthcare settings. However, global experience with multi-cancer early detection (MCED) tests and liquid biopsy shows that technology alone does not guarantee earlier diagnosis or reduced mortality. Purpose: This short communication proposes a pragmatic, pathway-first framework to complement tool-centric narratives and to help clinicians, policymakers, and innovators integrate emerging technologies into real-world primary healthcare systems, especially in low and middle-income countries (LMICs). Methods: A focused narrative synthesis of recent literature from 2022 to 2025 was performed on early cancer detection, MCED, liquid biopsy, biosensors, breath-based diagnostics, radiomics, and AI in oncology, prioritizing peer-reviewed sources indexed in major biomedical databases. Insights from implementation science and equity-oriented cancer control in LMICs were integrated to co-develop a framework aligned with healthcare delivery and organization. Results: Three key blind spots in purely tool-focused narratives were identified, namely limited integration of implementation science and health system readiness, insufficient attention to affordability, reimbursement, and financing, and lack of use-case clarity across screening, triage, diagnosis, and monitoring. To address these gaps, the PATHS framework is introduced: Performance for purpose, Access and affordability, Trust and ethics, Health system fit, and Sustainability. Its application is illustrated for wearable biosensors, breath-based tests, paper-based microfluidics, liquid biopsy, and radiomics or AI at different levels of care. Conclusions: Biotechnological innovation for early cancer detection is now rich and diverse. The next step is to embed these tools into implementable, equity-sensitive pathways. Adopting a PATHS lens can help readers move from asking “which tool is most exciting?” to “which tool, in which pathway, for which population, delivers the greatest real-world benefit?”, particularly in primary healthcare and LMIC settings where the marginal gains from earlier detection are greatest.
- 29 January 2026
- Published by Chitkara University Publications in Journal of Multidisciplinary Research in Healthcare
- Vol. 12 (1) , 50-55
Open AccessDigital AI-Based Sensing Technologies in Cancer Care: A PATHS Framework for Early Detection and Personalized Diagnosis
Background: Recent work has mapped a wide range of biotechnological tools for early cancer detection, ranging from microfluidics and liquid biopsy to biosensors, organoids, breath-based diagnostics, and artificial intelligence (AI), with explicit attention to primary and resource-constrained healthcare settings. However, global experience with multi-cancer early detection (MCED) tests and liquid biopsy shows that technology alone does not guarantee earlier diagnosis or reduced mortality. Purpose: This short communication proposes a pragmatic, pathway-first framework to complement tool-centric narratives and to help clinicians, policymakers, and innovators integrate emerging technologies into real-world primary healthcare systems, especially in low and middle-income countries (LMICs). Methods: A focused narrative synthesis of recent literature from 2022 to 2025 was performed on early cancer detection, MCED, liquid biopsy, biosensors, breath-based diagnostics, radiomics, and AI in oncology, prioritizing peer-reviewed sources indexed in major biomedical databases. Insights from implementation science and equity-oriented cancer control in LMICs were integrated to co-develop a framework aligned with healthcare delivery and organization. Results: Three key blind spots in purely tool-focused narratives were identified, namely limited integration of implementation science and health system readiness, insufficient attention to affordability, reimbursement, and financing, and lack of use-case clarity across screening, triage, diagnosis, and monitoring. To address these gaps, the PATHS framework is introduced: Performance for purpose, Access and affordability, Trust and ethics, Health system fit, and Sustainability. Its application is illustrated for wearable biosensors, breath-based tests, paper-based microfluidics, liquid biopsy, and radiomics or AI at different levels of care. Conclusions: Biotechnological innovation for early cancer detection is now rich and diverse. The next step is to embed these tools into implementable, equity-sensitive pathways. Adopting a PATHS lens can help readers move from asking “which tool is most exciting?” to “which tool, in which pathway, for which population, delivers the greatest real-world benefit?”, particularly in primary healthcare and LMIC settings where the marginal gains from earlier detection are greatest.
- 16 September 2023
- Published by Scientific Advanced Learning Technologies Trust in SALT Journal of Scientific Research in Healthcare
- p. 24-28
MANAGING MYOPIA CONTROL: A REVIEW OF PROVEN STRATEGIES
- 16 September 2023
- Published by Scientific Advanced Learning Technologies Trust in SALT Journal of Scientific Research in Healthcare
- p. 24-28
MANAGING MYOPIA CONTROL: A REVIEW OF PROVEN STRATEGIES